GlassScriptPhysician profile
Paul Debes
NPI 1891175840
$5,653.07
in general payments reported to CMS, 2019-2025
19 companies · $975 in 2025
The $975 reported for 2025 was more than what 85% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,238 · 2022: $932 · 2023: $1,178 · 2024: $1,330 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,482.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,432.81 | 2021-2025 | Dovato, Rukobia, Cabenuva |
| Gilead Sciences, INC. | $1,408.97 | 2021-2025 | Biktarvy, Descovy |
| Abbvie INC. | $864.11 | 2021-2025 | |
| Antares Pharma, INC. | $205.86 | 2021-2025 | Xyosted, Tlando |
| Merck Sharp & Dohme LLC | $201.38 | 2021-2025 | Pifeltro |
| Janssen Biotech, INC. | $125.81 | 2021-2023 | Symtuza |
| Janssen Products, LP | $82.95 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $69.36 | 2021-2024 | Abilify Asimtufii |
| Hologic Sales and Service, LLC | $45.41 | 2021-2025 | Aptima |
| Theratechnologies INC. | $41.59 | 2021-2023 | Trogarzo, Egrifta |
| Janssen Pharmaceuticals, INC | $38.77 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.87 | 2021 | |
| Indivior INC. | $20.03 | 2025 | Sublocade |
| Halozyme INC | $18.25 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.32 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $16.16 | 2023 | Nexplanon |
| Abbott Laboratories | $15.84 | 2022 | |
| Dynavax Technologies Corporation | $14.84 | 2022 | |
| Neurocrine Biosciences, INC. | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Debes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.